SG Pharma Consulting
SG Pharma Consulting, headquartered in the United States, is a leading player in the pharmaceutical consulting industry, specialising in regulatory affairs, market access, and strategic development. Founded in 2010, the company has established a strong presence across North America and Europe, providing expert guidance to clients navigating complex regulatory landscapes. With a focus on delivering tailored solutions, SG Pharma Consulting offers unique services that streamline the drug development process and enhance market entry strategies. Their team of seasoned professionals leverages extensive industry knowledge to help clients achieve compliance and optimise product launches. Recognised for their commitment to excellence, SG Pharma Consulting has garnered a reputation for reliability and innovation, positioning themselves as a trusted partner for pharmaceutical companies seeking to thrive in a competitive market.
DitchCarbon Score
How does SG Pharma Consulting's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Machinery and Equipment industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
SG Pharma Consulting's score of 10 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
SG Pharma Consulting's reported carbon emissions
In 2023, SG Pharma Consulting reported total carbon emissions of approximately 1,309,300 kg CO2e. This figure includes 911,300 kg CO2e from Scope 1 emissions, which primarily stem from mobile combustion and fugitive emissions, and 398,000 kg CO2e from Scope 2 emissions, attributed to purchased electricity. Despite the significant emissions, there are currently no documented reduction targets or initiatives outlined by SG Pharma Consulting. The absence of specific climate pledges or commitments suggests that the company may still be in the early stages of developing a comprehensive climate strategy. As the pharmaceutical industry increasingly prioritises sustainability, SG Pharma Consulting's future commitments will be crucial in aligning with global climate goals and reducing their carbon footprint.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2023 | |
|---|---|
| Scope 1 | 911,300 |
| Scope 2 | 398,000 |
| Scope 3 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
SG Pharma Consulting is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
